Botulinum Toxin for Post Abdominoplasty Pain Control
Status:
Not yet recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
We are investigating ways to reduce pain after abdominoplasty. We hypothesize that injection
of Dysport (botulinum toxin A) into the rectus abdominis, abdominal wall musculature, during
abdominoplasty will provide a more effective, longer lasting method for pain control than
standard of care alone (use of Exparel (liposomal bupivacaine) intraoperatively followed by
PRN narcotics. We will randomize patients to receive either Disport + standard of care or
saline (placebo) + standard of care and compare post operative pain for the following 2-3
months.
Phase:
Phase 4
Details
Lead Sponsor:
Virginia Commonwealth University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA